Intro -- Foreword -- Preface -- Contents -- 1: Epidemiology, Presentation, Staging, and Prognostic Factors in Adrenocortical Carcinoma -- 1.1 Epidemiology -- 1.2 Clinical Presentation -- 1.3 Staging and Risk Assessment -- References -- 2: Epidemiology, Presentation, Staging, and Prognostic Factors in Malignant Pheochromocytoma -- 2.1 Introduction -- 2.2 Presentation -- 2.3 Biochemical Diagnosis -- 2.4 Perioperative Management -- 2.5 Staging -- 2.6 Prognostic Factors -- 2.7 Postoperative Follow-Up -- References -- 3: Genetics and Molecular Biology of Adrenocortical Carcinoma -- 3.1 Introduction -- 3.2 Germline DNA Mutations and the Hereditary Component of Adrenocortical Carcinoma -- 3.3 Chromosomal Number Alteration (Aneuploidy) -- 3.4 Somatic DNA Mutations and Tumor Mutation Burden -- 3.5 Epigenetic (Post-Translational) Changes -- 3.6 An Integrative View of Molecular Biology of Adrenocortical Carcinoma -- 3.7 Spatial/Temporal Molecular Heterogeneity in Adrenocortical Carcinoma -- References -- 4: Genetics and Molecular Biology of Pheochromocytoma and Paraganglioma -- 4.1 Introduction -- 4.2 NF1 Gene -- 4.3 RET Gene -- 4.4 VHL Gene -- 4.5 SDHx Genes and SDHAF2 Gene -- 4.5.1 SDHD Gene (PGL1 Syndrome) -- 4.5.2 SDHAF2 Gene (PGL2 Syndrome) -- 4.5.3 SDHC Gene (PGL3 Syndrome) -- 4.5.4 SDHB Gene (PGL4 Syndrome) -- 4.5.5 SDHA Gene (PGL5 Syndrome) -- 4.6 TMEM127 Gene -- 4.7 MAX Gene -- 4.8 FH Gene -- 4.9 Other Genes -- 4.10 Molecular Biology -- References -- 5: Imaging in Adrenocortical |